Cargando…
Why pulsatility still matters: a review of current knowledge
Continuous-flow left ventricular assist devices (LVAD) have become standard therapy option for patients with advanced heart failure. They offer several advantages over previously used pulsatile-flow LVADs, including improved durability, less surgical trauma, higher energy efficiency, and lower throm...
Autor principal: | Barić, Davor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Croatian Medical Schools
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295069/ https://www.ncbi.nlm.nih.gov/pubmed/25559832 http://dx.doi.org/10.3325/cmj.2014.55.609 |
Ejemplares similares
-
A systematic review and physiology of pulmonary artery pulsatility index in left ventricular assist device therapy
por: Yim, Ivan H W, et al.
Publicado: (2023) -
Antithrombotics in heart failure
por: Miličić, Davor, et al.
Publicado: (2014) -
Cardiac allograft vasculopathy: diagnosis, therapy, and prognosis
por: Skorić, Boško, et al.
Publicado: (2014) -
Results of extracorporeal life support implementation in routine clinical practice: single center experience
por: Biočina, Bojan, et al.
Publicado: (2014) -
Current state-of-the-art of device therapy for advanced heart failure
por: Lee, Lawrence S., et al.
Publicado: (2014)